Overview
Michael Kraut is an Oncologist practicing medicine in Southfield, Michigan.
Dr. Kraut is highly rated in 18 conditions, according to our data. His clinical expertise encompasses Pleuropulmonary Blastoma, Astrocytoma, Oligodendroglioma, and Multiple Myeloma.
He is actively involved in clinical research, co-authoring 17 peer reviewed articles and participating in 17 clinical trials.
Specialties
Licenses
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- POS
Locations
22301 Foster Winter Dr, Southfield, MI 48075
47601 Grand River Ave, Novi, MI 48374
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
17 Clinical Trials
Henry Ford Cancer-Detroit
Shirish Gadgeel is an Oncologist practicing medicine in Detroit, Michigan. Dr. Gadgeel is highly rated in 15 conditions, according to our data. His clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Squamous Cell Lung Carcinoma, EGFR Positive Lung Cancer, and Tissue Biopsy.
Henry Ford Cancer-Detroit
Philip Philip is an Oncologist practicing medicine in Detroit, Michigan. Dr. Philip is highly rated in 31 conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Colorectal Cancer, Neuroendocrine Tumor, Pancreatectomy, and Liver Embolization.
Rogel Cancer Center
Dr. Francis Worden received his medical degree from the Indiana University School of Medicine in 1993. Prior to attending medical school, he worked as a registered pharmacist at a large community hospital in Indianapolis. In 1997, Dr. Worden completed a combined residency in internal medicine and pediatrics at the Detroit Medical Center and finished a medical oncology/hematology fellowship at the University of Michigan. In July 2000, Dr. Worden joined the faculty at the University of Michigan Rogel Cancer Center, where he is currently working as a clinical investigator with both the multidisciplinary head and neck oncology team and the multidisciplinary lung cancer team. Dr. Worden's research interests include organ preservation in head and neck cancer and endocrine oncology. He is the Nancy Wigginton Oncology Research Professor of Thyroid Cancer. Avid competitive swimmer ; cyclist and runner. Dr. Worden is highly rated in 33 conditions, according to our data. His clinical expertise encompasses Laryngeal Cancer, Throat Cancer, Thyroid Cancer, and Head and Neck Squamous Cell Carcinoma (HNSCC). Dr. Worden is board certified in Medical Oncology.
Frequently Asked Questions about Dr. Michael Kraut
How do I make an appointment with Dr. Michael Kraut?
You can book an appointment with Dr. Michael Kraut by calling their office at 248-552-0620. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Michael Kraut a top-rated expert for Pleuropulmonary Blastoma?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Michael Kraut is classified as an Distinguished expert for Pleuropulmonary Blastoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Michael Kraut specialize in?
While Dr. Michael Kraut is a Oncology, they have specific expertise in Pleuropulmonary Blastoma, Astrocytoma, and Oligodendroglioma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.
Does Dr. Michael Kraut participate in research or clinical trials?
Yes. Dr. Michael Kraut has published 17 articles and abstracts on conditions like Pleuropulmonary Blastoma. You can view a list of Dr. Michael Kraut's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Michael Kraut accept my insurance?
Dr. Michael Kraut accepts most major insurance plans, including Aetna and Blue Cross Blue Shield. We recommend calling the office directly at 248-552-0620 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Pleuropulmonary BlastomaDr. Kraut isDistinguished. Learn about Pleuropulmonary Blastoma.
- Advanced
- ALK-Positive Non-Small Cell Lung Cancer
- AstrocytomaDr. Kraut isAdvanced. Learn about Astrocytoma.
- Atypical Teratoid Rhabdoid Tumor (ATRT)
- EGFR Positive Lung CancerDr. Kraut isAdvanced. Learn about EGFR Positive Lung Cancer.
- Embryonal Tumor with Multilayered Rosettes
- EpendymomaDr. Kraut isAdvanced. Learn about Ependymoma.
- Experienced
- AgranulocytosisDr. Kraut isExperienced. Learn about Agranulocytosis.
- Ampullary CancerDr. Kraut isExperienced. Learn about Ampullary Cancer.
- AngiosarcomaDr. Kraut isExperienced. Learn about Angiosarcoma.
- Atypical Hemolytic Uremic Syndrome (aHUS)
- Brain TumorDr. Kraut isExperienced. Learn about Brain Tumor.
- Breast CancerDr. Kraut isExperienced. Learn about Breast Cancer.

